Plasma EGF levels predict cognitive decline in Parkinson's Disease

OBJECTIVE: Most people with Parkinson's disease (PD) eventually develop cognitive impairment (CI). However, neither the timing of onset nor the severity of cognitive symptoms can be accurately predicted. We sought plasma-based biomarkers for CI in PD. METHODS: A discovery cohort of 70 PD patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chen-Plotkin, Alice S., Hu, William T., Siderowf, Andrew, Weintraub, Daniel, Gross, Rachel Goldmann, Hurtig, Howard I., Xie, Sharon X., Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., McCluskey, Leo, Elman, Lauren, Van Deerlin, Vivianna M., Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155276/
https://ncbi.nlm.nih.gov/pubmed/21520231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.22271
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars